Physician profile
Reyzan E Shali
NPI 1245245018
$5,323.19
in general payments reported to CMS, 2019-2025
48 companies · $846 in 2025
The $846 reported for 2025 was more than what 82% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $240 · 2020: $60.41 · 2021: $341 · 2022: $1,658 · 2023: $970 · 2024: $1,208 · 2025: $846.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,024.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,023.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $621.89 | 2021-2025 | Vraylar, Ubrelvy, Dalvance |
| Astrazeneca Pharmaceuticals LP | $602.08 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Lilly USA, LLC | $447.23 | 2019-2024 | Mounjaro, Zepbound, Jardiance |
| Sumitomo Pharma America, INC. | $422.92 | 2023-2024 | Gemtesa |
| Amgen INC. | $400.87 | 2021-2023 | Repatha, Otezla, Evenity |
| Pfizer INC. | $300.11 | 2019-2025 | |
| Glaxosmithkline, LLC. | $276.05 | 2022-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Bayer Healthcare Pharmaceuticals INC. | $186.67 | 2022-2023 | |
| Boston Scientific Corporation | $170.42 | 2024-2025 | Wavewriter Alpha Prime 16, Watchman Flx |
| Teva Pharmaceuticals USA, INC. | $126.39 | 2019-2025 | Austedo Xr, Austedo Xr |
| Janssen Pharmaceuticals, INC | $121.10 | 2022-2025 | Xarelto, Spravato |
| Otsuka America Pharmaceutical, INC. | $100.87 | 2023-2025 | Rexulti |
| Biogen, INC. | $99.99 | 2021 | |
| Seqirus USA INC | $98.84 | 2021-2024 | Flucelvax, Fluad, Flucelvax Quadrivalent |
| Medtronic, INC. | $97.08 | 2022 |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $90.20 | 2021-2024 | Tradjenta, Jardiance |
| Novo Nordisk INC | $84.71 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Lundbeck LLC | $73.87 | 2023-2025 | Rexulti |
| Tactile Systems Technology INC | $70.46 | 2022-2025 | Nimbl, Flexitouch Plus |
| Merck Sharp & Dohme LLC | $69.74 | 2021-2025 | Capvaxive, Gardasil 9, Belsomra |
| Eisai INC. | $68.13 | 2021-2022 | |
| Mannkind Corporation | $66.26 | 2021-2022 | |
| Linus Health, INC. | $55.43 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $54.37 | 2022 | |
| Si-Bone, INC. | $46.56 | 2021-2024 | |
| Astellas Pharma US INC | $45.40 | 2024 | Veozah |
| Novartis Pharmaceuticals Corporation | $44.73 | 2021-2022 | |
| Exact Sciences Corporation | $43.79 | 2023-2024 | Cologuard Collection Kit |
| W. L. Gore & Associates, INC. | $42.44 | 2024 | Gore Cardioform Septal Occluder |
| Nevro Corp. | $39.89 | 2022 | |
| Abbott Laboratories | $38.87 | 2023-2025 | Mitraclip, Freestyle Libre 3 |
| Alnylam Pharmaceuticals INC. | $29.93 | 2025 | Amvuttra |
| Tandem Diabetes Care, INC. | $29.29 | 2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Edwards Lifesciences Corporation | $24.34 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Smith+Nephew, INC. | $22.66 | 2025 | Collagenase Santyl |
| Sun Pharmaceutical Industries INC. | $19.92 | 2022 | |
| Cequr Corporation | $19.16 | 2024 | Cequr Simplicity |
| Aytu Biopharma, INC. | $19.15 | 2019 | |
| Hologic Sales and Service, LLC | $18.10 | 2022 | |
| Atricure, INC. | $17.35 | 2020 | |
| Almatica Pharma LLC | $17.22 | 2022 | |
| Abiomed | $16.19 | 2024 | Impella |
| Philips North America LLC | $15.78 | 2024 | (Ck7) Extended Holter |
| E.R. Squibb & Sons, L.L.C. | $15.54 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $14.50 | 2025 | Zoryve |
| Sanofi-Aventis U.S. LLC | $12.47 | 2022 | |
| Janssen Biotech, INC. | $12.13 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $12.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reyzan Shali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.